{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:59:58Z","timestamp":1756310398715,"version":"3.44.0"},"reference-count":24,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2024,2,28]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:p>Dimenhydrinate is an over-the-counter antihistaminergic medication with anticholinergic properties used to treat nausea or motion sickness worldwide. There is a well-established correlation between the use of anticholinergic medications and dementia, however, it is unclear if a causal role exists. We report a case of minor neurocognitive disorder in a woman in her 40s with several years of high-dose daily dimenhydrinate abuse who subsequently developed significant delusional beliefs. Her clinical presentation was confounded by numerous other factors that could have impacted her cognition, such as a longstanding presumed learning disability, ankylosing spondylitis with adalimumab treatment, extensive cannabis use or potential development of a primary psychotic disorder. Her workup was within normal limits, and she has not responded to first-line antipsychotic medications to date. This case report adds to the growing evidence supporting concerns about potentially irreversible cognitive deficits in chronic misuse of anticholinergic agents, an association previously observed only in the elderly population.<\/jats:p>","DOI":"10.1136\/bcr-2023-258493","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T12:01:33Z","timestamp":1709812893000},"page":"e258493","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Chronic high-dose dimenhydrinate use contributing to early multifactorial cognitive impairment"],"prefix":"10.1136","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6873-5105","authenticated-orcid":false,"given":"Nicholas","family":"Fabiano","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saumil","family":"Dholakia","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Department of Mental Health, Ottawa Hospital, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5865-7257","authenticated-orcid":false,"given":"Lisa A S","family":"Walker","sequence":"additional","affiliation":[{"name":"Neuroscience, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6793-2926","authenticated-orcid":false,"given":"Andrew L","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Department of Mental Health, Ottawa Hospital, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"issue":"Suppl 2","key":"2025082707100299000_17.3.e258493.1","first-page":"20","article-title":"Managing anticholinergic side effects","volume":"6","author":"Lieberman","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"2025082707100299000_17.3.e258493.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7634(01)00038-0"},{"key":"2025082707100299000_17.3.e258493.3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2025082707100299000_17.3.e258493.4","article-title":"Anticholinergic burden (Prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome","volume":"5","author":"Taylor-Rowan","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2025082707100299000_17.3.e258493.5","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.154.5.672"},{"key":"2025082707100299000_17.3.e258493.6","doi-asserted-by":"publisher","DOI":"10.2174\/1745017901309010088"},{"key":"2025082707100299000_17.3.e258493.7","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.44.5.388"},{"key":"2025082707100299000_17.3.e258493.8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/alzrt274","article-title":"The clinical characteristics of dementia with Lewy bodies and a consideration of Prodromal diagnosis","volume":"6","author":"Donaghy","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"2025082707100299000_17.3.e258493.9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00296-022-05248-4","article-title":"Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis","volume":"43","author":"Kleinert","year":"2023","journal-title":"Rheumatol Int"},{"key":"2025082707100299000_17.3.e258493.10","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2021.669","article-title":"Immunotherapy and psychosis: it there a risk?","volume":"64","author":"Barbosa","year":"2021","journal-title":"Eur Psychiatr"},{"key":"2025082707100299000_17.3.e258493.11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jcyt.2019.04.054","article-title":"Adalimumab improves cognitive impairment, exerts neuroprotective effects and attenuates neuroinflammation in an A\u03b21-40-injected mouse model of Alzheimer\u2019s disease","volume":"21","author":"Park","year":"2019","journal-title":"Cytotherapy"},{"key":"2025082707100299000_17.3.e258493.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-072348","article-title":"Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies","volume":"382","author":"Solmi","year":"2023","journal-title":"BMJ"},{"key":"2025082707100299000_17.3.e258493.13","doi-asserted-by":"publisher","DOI":"10.1037\/a0029117"},{"key":"2025082707100299000_17.3.e258493.14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.drugalcdep.2016.10.022","article-title":"A longitudinal examination of the relationship between cannabis use and cognitive function in mid-life adults","volume":"169","author":"McKetin","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"2025082707100299000_17.3.e258493.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2011.08.025"},{"key":"2025082707100299000_17.3.e258493.16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.eurpsy.2018.09.010","article-title":"Cognition and functionality in delusional disorder","volume":"55","author":"D\u00edaz-Caneja","year":"2019","journal-title":"Eur Psychiatr"},{"key":"2025082707100299000_17.3.e258493.17","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/ageing\/afaa090","article-title":"Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis","volume":"49","author":"Pieper","year":"2020","journal-title":"Age Ageing"},{"key":"2025082707100299000_17.3.e258493.18","first-page":"184","article-title":"A patient with dimenhydrinate dependence: a case report","volume":"24","author":"Kaya","year":"2014","journal-title":"Klin Psikofarmakol B\u00fcl-Bull Clin Psychopharmacol"},{"key":"2025082707100299000_17.3.e258493.19","first-page":"970","article-title":"Dimenhydrinate dependence and withdrawal","volume":"142","author":"Craig","year":"1990","journal-title":"CMAJ Can Med Assoc J"},{"key":"2025082707100299000_17.3.e258493.20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/070674379303800208","article-title":"Dimenhydrinate abuse among adolescents","volume":"38","author":"Gardner","year":"1993","journal-title":"Can J Psychiatry"},{"key":"2025082707100299000_17.3.e258493.21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpsychires.2020.10.032","article-title":"Misuse and dependence of dimenhydrinate: a mixed studies systematic review","volume":"136","author":"Bahji","year":"2021","journal-title":"J Psychiatr Res"},{"key":"2025082707100299000_17.3.e258493.22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38740.439664.DE"},{"key":"2025082707100299000_17.3.e258493.23","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10639"},{"key":"2025082707100299000_17.3.e258493.24","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1038\/s41380-020-0834-1","article-title":"Older molecular brain age in severe mental illness","volume":"26","author":"Lin","year":"2021","journal-title":"Mol Psychiatry"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2023-258493","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T14:10:12Z","timestamp":1756303812000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2023-258493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,7]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/bcr-2023-258493"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2023-258493","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}